Advisors Asset Management, Inc. Legend Biotech Corp Transaction History
Advisors Asset Management, Inc.
- $5.1 Billion
- Q1 2025
A detailed history of Advisors Asset Management, Inc. transactions in Legend Biotech Corp stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 19,825 shares of LEGN stock, worth $746,213. This represents 0.01% of its overall portfolio holdings.
Number of Shares
19,825
Previous 6,755
193.49%
Holding current value
$746,213
Previous $219,000
206.85%
% of portfolio
0.01%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding LEGN
# of Institutions
229Shares Held
74.4MCall Options Held
247KPut Options Held
406K-
Westfield Capital Management CO LP Boston, MA6.92MShares$260 Million1.21% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.73MShares$253 Million0.03% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$225 Million6.23% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$215 Million0.01% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.75MShares$141 Million5.57% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.3B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...